Added to YB: 2025-12-26
Pitch date: 2025-12-22
CAMP [neutral]
Camp4 Therapeutics Corporation
-25.08%
current return
Author Info
everyonehatespoetry is an equities analyst sharing his best special situations / GARP ideas, mostly small and micro caps. Sign up for the newsletter.
Company Info
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases.
Market Cap
$199.7M
Pitch Price
$5.94
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.74
P/E
-1.53
EV/Sales
34.41
Sector
Biotechnology
Category
special_situation
Orders & awards monitor - week 1 - Camp4 Therapeutics
CAMP (update): GSK partnership with $17.5M upfront + up to $440M milestones + royalties for antisense oligonucleotide therapeutics targeting neurodegenerative & kidney diseases. $330M market cap, $260M EV. Major validation from Big Pharma partner with significant financial backing.
Read full article (1 min)